Incidence of adrenal insufficiency and impact of corticosteroid supplementation in critically ill children with systemic inflammatory syndrome and vasopressor-dependent shock

Critical Care Medicine

Volumn 39, Issue 5, 2011, Pages 1145-1150

  Hebbar, Kiran B ^a   Stockwell, Jana A ^a   Leong, Traci ^b   Fortenberry, James D ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY   (United States)

Author keywords

adrenal insufficiency; cortisol; critical care; pediatric; systemic inflammatory response syndrome

Indexed keywords

ALBUMIN; CORTICOSTEROID; CORTICOTROPIN; DOPAMINE; FLUDROCORTISONE; GLUCOSE; HYDROCORTISONE; HYPERTENSIVE FACTOR; INSULIN; NORADRENALIN; TETRACOSACTIDE;

ADOLESCENT; ADRENAL INSUFFICIENCY; ADULT; ALBUMIN BLOOD LEVEL; ANTIBIOTIC THERAPY; ARTIFICIAL VENTILATION; BLOOD GLUCOSE MONITORING; CANDIDA ALBICANS; CAPNOCYTOPHAGA; CHILD; CONFERENCE PAPER; CONTROLLED STUDY; CORTICOSTEROID THERAPY; CORTICOTROPIN TEST; CRITICALLY ILL PATIENT; DISEASE DURATION; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; ENTEROBACTER CLOACAE; ENTEROCOCCUS FAECALIS; ESCHERICHIA COLI; FEMALE; FLUID RESUSCITATION; HAEMOPHILUS INFLUENZAE; HUMAN; HYPERGLYCEMIA; HYPOTENSION; INCIDENCE; INFANT; KLEBSIELLA PNEUMONIAE; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; METAPNEUMOVIRUS; MORAXELLA CATARRHALIS; PARAINFLUENZA VIRUS; PRESCHOOL CHILD; PRESSOR RESPONSE; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RETROSPECTIVE STUDY; SCHOOL CHILD; SECONDARY INFECTION; SEPTIC SHOCK; STAPHYLOCOCCAL BACTEREMIA; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 79955483354     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e31820eb4e4     Document Type: Conference Paper

References (30)

1. Annane D, Maxime V, Ibrahim F, et al: Diag-nosis of adrenal insufficiency in severe sepsis and septic shock. Am J Respir Crit Care Med 2006; 174:1319-1326 (Pubitemid 44913033)
2. Coursin DB, Wood KE: Corticosteroid sup-plementation for adrenal insufficiency. JAMA 2002; 287:236-240
3. Lipiner-Friedman D, Sprung CL, Laterre PF, et al: Adrenal function in sepsis: the retro-spective Corticus cohort study. Crit Care Med 2007; 35:1012-1018 (Pubitemid 46598949)
4. Annane D, Sébille V, Charpentier C, et al: Effect of treatment with low doses of hydro-cortisone and fludrocortisone on mortality in patients with septic shock. JAMA 2002; 288: 862-871
5. De Dooy JJ, Dijkkamp A, Kneyber MC, et al: Diagnosis and therapy of adrenal insuffi-ciency in pediatric septic shock: from theory to practice. Crit CareMed 2009; 37:796-797; author reply 797-798
6. Annetta M, Maviglia R, Proietti R, Antonelli M: Use of corticosteroids in critically ill sep-tic patients: a review of mechanisms of adre-nal insufficiency in sepsis and treatment. Curr Drug Targets 2009; 10:887-894
7. Hebbar K, Rigby MR, Felner EI, et al: Neu-roendocrine dysfunction in pediatric critical illness. Pediatr Crit Care Med 2009; 10: 35-40
8. Menon K, Ward RE, Lawson ML, et al: A prospective multicenter study of adrenal function in critically ill children. Am JRespir Crit Care Med; 182:246-251
9. Boyer A, Chadda K, Salah A, Annane D: Glu-cocorticoid treatment in patients with septic shock: effects on vasopressor use and mor-tality. Int J Clin Pharmacol Ther 2006; 44: 309-318 (Pubitemid 44043773)
10. Taketomo CK: Fludrocortisone. In: Pediatric Dosage Hand-Book. 6th ed. Hodding JH, Kraus DM (Eds). Cleveland, OH, Lexi-Comp Inc. 1999; p 2000
11. Preissig CM, Hansen I, Roerig PL, Rigby MR: A protocolized approach to identify and man-age hyperglycemia in a pediatric critical care unit. Pediatr Crit Care Med 2008; 9:581-588
12. Zhang YC, Zhang SJ, Teng GL, et al: [Adrenal function evaluation using ACTH stimulation test in children with sepsis and septic shock.] Zhonghua Er Ke Za Zhi 2008; 46:328-332
13. Dellinger RP, Levy MM, Carlet JM, et al: Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008. Intensive Care Med 2008; 34:17-60
14. Gonzalez H, Nardi O, Annane D: Relative adrenal failure in the ICU: An identifiable problem requiring treatment. Crit Care Clin 2006; 22:105-118; vii (Pubitemid 43037112)
15. Brierley J, Carcillo JA, Choong K, et al: Clin-ical practice parameters for hemodynamic support of pediatric and neonatal septic shock: 2007 update from the American Col-lege of Critical Care Medicine. Crit Care Med 2009; 37:666-688
16. Leteurtre S, Martinot A, Duhamel A, et al: Validation of the paediatric logistic organ dysfunction (PELOD) score: prospective, ob-servational, multicentre study. Lancet 2003; 362:192-197 (Pubitemid 36859934)
17. Leteurtre S, Duhamel A, Grandbastien B, et al: Paediatric logistic organ dysfunction (PELOD) score. Lancet 2006; 367:897; au-thor reply 900-892
18. Bilan N, Galehgolab BA, Emadaddin A, Shiva S: Risk of mortality in pediatric intensive care unit, assessed by PRISM-III. Pak J Biol Sci 2009; 12:480-485
19. Pollack MM, Patel KM, Ruttimann UE: PRISM III: An updated Pediatric Risk of Mor-tality score. Crit Care Med 1996; 24:743-752 (Pubitemid 26155716)
20. Zimmerman JJ: A history of adjunctive glu-cocorticoid treatment for pediatric sepsis: moving beyond steroid pulp fiction toward evidence-based medicine. Pediatr Crit Care Med 2007; 8:530-539 (Pubitemid 350076458)
21. Dellinger RP, Levy MM, Carlet JM, et al: Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 2008; 36:296-327
22. Marik PE: Critical illness-related corticoste-roid insufficiency. Chest 2009; 135:181-193
23. Zimmerman JJ, Williams MD: Adjunctive corticosteroid therapy in pediatric severe sepsis: Observations from the RESOLVE study. Pediatr Crit Care Med 2011; 12:2-8
24. Stark AR, Carlo WA, Tyson JE, et al: Adverse effects of early dexamethasone in extremely-low-birth-weight infants. National Institute of Child Health and Human Development Neonatal Research Network. N Engl J Med 2001; 344:95-101
25. Sprung CL, Annane D, Keh D, et al: Hydro-cortisone therapy for patients with septic shock. N Engl J Med 2008; 358:111-124
26. Finfer S: Corticosteroids in septic shock. NEngl J Med 2008; 358:188-190
27. Druce LA, Thorpe CM, Wilton A: Mineralo-corticoid effects due to cortisol inactivation overload explain the beneficial use of hydro-cortisone in septic shock. Med Hypotheses 2008; 70:56-60 (Pubitemid 350167497)
28. Keh D, Sprung CL: Use of corticosteroid therapy in patients with sepsis and septic shock: An evidence-based review. Crit Care Med 2004; 32(Suppl 11):S527-S533 (Pubitemid 39489025)
29. COIITSS Study Investigators, Annane D, Cariou A, et al: Corticosteroid treatment and intensive insulin therapy for septic shock in adults: A randomized controlled trial. JAMA 2010; 303:341-348
30. Hebbar K, Stockwell J, Fortenberry JD: Clin-ical effects of adding fludrocortisone to a hydrocortisone-based shock protocol in hy-potensive critically ill children. Intensive Care Med 2010; In Press